Propofol, an agonist of the GABAA receptor, is a small molecule drug primarily used for anesthesia.

Epinephrine, a minute molecule drug, exerts its action as an adrenergic receptor agonist by targeting the adrenergic receptor, exhibiting an extensive list of active indications.

Progesterone, a diminutive molecule drug, acts as a modulator of the progesterone receptor (PR), exhibiting a broad spectrum of active indications.

Glutathione, a diminutive molecule drug, is a versatile medication used to treat a diverse range of medical conditions.

Ezetimibe, an enigmatic small molecule drug, bewilders the medical community with its ability to inhibit the NPC1L1 protein.

Chlorthalidone, a small molecule drug, operates via the inhibition of the NCC protein that is responsible for sodium and chloride reabsorption in the kidneys.

Takeda Pharmaceutical's approval of colchicine in January 1995 marked a significant milestone in the world of medicine.

Benzoyl peroxide, a small molecule drug with potent antibacterial properties, was originally sanctioned in January 1968 by Maruho Pharmaceutical for treating acne.

Levetiracetam, a diminutive molecular entity, has been engineered to hone in on the synaptic vesicle protein 2A (SV2A) as a modulation target.

Ketoconazole, a diminutive molecular compound, functions as an inhibitor of CYP51A1.

Misoprostol is a small molecule drug that exerts its pharmacological effects through the activation of EP2 receptors in the body.

Atendol, a small molecule drug, falls under the ambit of the β1-adrenergic receptor antagonists class.